Search Count: 8
 |
Design And Application Of Synthetic 17B-Hsd13 Substrates To Drug Discovery, And To Reveal Preserved Catalytic Activity Of Protective Human Variants
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2024-11-27 Classification: HYDROLASE Ligands: NAD, A1AG4 |
 |
Design And Application Of Synthetic 17B-Hsd13 Substrates To Drug Discovery, And To Reveal Preserved Catalytic Activity Of Protective Human Variants
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.36 Å Release Date: 2024-11-27 Classification: HYDROLASE Ligands: NAD, A1AG5 |
 |
Design And Application Of Synthetic 17B-Hsd13 Substrates To Drug Discovery, And To Reveal Preserved Catalytic Activity Of Protective Human Variants
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2024-11-27 Classification: HYDROLASE Ligands: NAD, A1AG6 |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2024-05-15 Classification: VIRAL PROTEIN Ligands: YDL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2021-11-10 Classification: HYDROLASE/INHIBITOR Ligands: 4W8 |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2021-11-10 Classification: HYDROLASE/INHIBITOR Ligands: 4WI |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2021-11-10 Classification: HYDROLASE/INHIBITOR Ligands: 4YG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2021-11-10 Classification: HYDROLASE/INHIBITOR Ligands: 4WI |